BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11854231)

  • 1. Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
    Jakobsen H; Bjarnarson S; Del Giudice G; Moreau M; Siegrist CA; Jonsdottir I
    Infect Immun; 2002 Mar; 70(3):1443-52. PubMed ID: 11854231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
    Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
    Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice.
    Bjarnarson SP; Adarna BC; Benonisson H; Del Giudice G; Jonsdottir I
    J Immunol; 2012 Aug; 189(3):1265-73. PubMed ID: 22753937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antibody response to pneumococcal glycoconjugates and the effect of heat-labile enterotoxin on IGg subclasses after intranasal immunization.
    Jakobsen H; Adarna BC; Schulz D; Rappuoli R; Jonsdottir I
    J Infect Dis; 2001 May; 183(10):1494-500. PubMed ID: 11319685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.
    Bjarnarson SP; Jakobsen H; Del Giudice G; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2005 Apr; 35(4):1037-45. PubMed ID: 15756644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy.
    Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvants Enhance the Induction of Germinal Center and Antibody Secreting Cells in Spleen and Their Persistence in Bone Marrow of Neonatal Mice.
    Aradottir Pind AA; Dubik M; Thorsdottir S; Meinke A; Harandi AM; Holmgren J; Del Giudice G; Jonsdottir I; Bjarnarson SP
    Front Immunol; 2019; 10():2214. PubMed ID: 31616417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
    Bonenfant C; Dimier-Poisson I; Velge-Roussel F; Buzoni-Gatel D; Del Giudice G; Rappuoli R; Bout D
    Infect Immun; 2001 Mar; 69(3):1605-12. PubMed ID: 11179334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells.
    Olafsdottir TA; Hannesdottir SG; Giudice GD; Trannoy E; Jonsdottir I
    Scand J Immunol; 2007 Oct; 66(4):426-34. PubMed ID: 17850587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
    Jakobsen H; Saeland E; Gizurarson S; Schulz D; Jónsdóttir I
    Infect Immun; 1999 Aug; 67(8):4128-33. PubMed ID: 10417183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
    Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
    Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice.
    Richter MY; Jakobsen H; Haeuw JF; Power UF; Jonsdottir I
    Infect Immun; 2005 Feb; 73(2):956-64. PubMed ID: 15664938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006.
    Brynjolfsson SF; Bjarnarson SP; Mori E; Del Giudice G; Jonsdottir I
    Vaccine; 2008 Aug; 26(35):4557-62. PubMed ID: 18597905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.
    Richter MY; Jakobsen H; Birgisdottir A; Haeuw JF; Power UF; Del Giudice G; Bartoloni A; Jonsdottir I
    Infect Immun; 2004 Jan; 72(1):187-95. PubMed ID: 14688096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
    Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
    Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.
    Baudner BC; Balland O; Giuliani MM; Von Hoegen P; Rappuoli R; Betbeder D; Del Giudice G
    Infect Immun; 2002 Sep; 70(9):4785-90. PubMed ID: 12183520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
    Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
    Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.